These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18930140

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F.
    Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA.
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [Abstract] [Full Text] [Related]

  • 5. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish.
    Ross OA, O'Neill C, Rea IM, Lynch T, Gosal D, Wallace A, Curran MD, Middleton D, Gibson JM.
    Hum Immunol; 2004 Apr; 65(4):340-6. PubMed ID: 15120188
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P.
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z, Li D, Wu M, Xiang B, Wang L, Zhou M, Chen P, Li X, Shen S, Li G.
    BMC Mol Biol; 2008 Nov 03; 9():99. PubMed ID: 18976507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure.
    Shiao YH, Crawford EB, Anderson LM, Patel P, Ko K.
    Toxicol Appl Pharmacol; 2005 Jun 15; 205(3):290-6. PubMed ID: 15922014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Establishment of de novo DNA methylation patterns. Transcription factor binding and deoxycytidine methylation at CpG and non-CpG sequences in an integrated adenovirus promoter.
    Toth M, Müller U, Doerfler W.
    J Mol Biol; 1990 Aug 05; 214(3):673-83. PubMed ID: 2143784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT, Nuyan O, Tunc T, Yorubulut M, Unal AE, Inan LE.
    Neurol India; 2004 Sep 05; 52(3):332-7. PubMed ID: 15472421
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.